Steam Sterilization Patents: Who Leads, Where the Gaps Are 2026
- Concentrated but not locked up. the top 5 assignees hold 34.1% of all 979 records and the top 10 hold 51.1% — leaving roughly half the field to a long tail of single- and few-filing entrants.
- Filing has cooled from its peak. activity peaked at 52 records in 2018 and fell -76% from 49 records in 2021 to 12 in 2024, the last year the data can treat as complete.
- Sterilization science dominates the claims. A61L covers 65.5% of records, but a meaningful share also sits in material testing (G01N, 22.5%) and packaging (B65B, 6.8%), pointing to cross-class claim strategies.
Filing growth compares 2021 (49 records) with 2024 (12) — a three-year span. 2024 is the most recent year we treat as complete: publication lags filing by roughly 18 months, so 2025 onwards are still filling in and any growth rate that ends there would understate the field. Top-5 share is the combined record count of the five largest assignees divided by all 979 records in scope (CR5), not by the ranked leaders only.
What this landscape covers
Steam sterilization and load validation patents describe the hardware, chemistry and measurement methods used to prove that an autoclave cycle has actually delivered lethal conditions throughout a load — not just at the chamber sensor. That includes saturated steam quality checks, air removal verification, penetration testing into dense or wrapped loads, lethality calculation methods, and the perennial failure mode of wet pack after cycle completion. The dataset in scope spans 979 published records filed or published between 2015 and mid-2026.
Filing in this field is driven less by novel sterilization chemistry than by instrumentation and validation methodology: indicators, sensors, data-logging and statistical cycle qualification. That shapes where the claim density sits and where it does not.
Filing trends and technology composition
Two views of the same 979 records: how filing activity has moved year over year, and which IPC subclasses carry the claims.
A 2018 peak followed by a sustained pull-back
Annual filings rose to a peak of 52 records in 2018, then declined; the -76% drop from 49 records in 2021 to 12 in 2024 is the clearest complete-year comparison available. Records from 2025 and 2026 are still arriving in the data as publication catches up with filing, so the most recent two years understate true activity and should not be read as a continued fall.
Sterilization claims lead, but testing and packaging classes matter
A61L (sterilising and disinfecting) appears on 65.5% of the 979 records, confirming this is the core class. G01N (material analysis and testing) at 22.5% and C12Q (enzyme/DNA-based testing) at 12.9% show how much of the field is actually about proving sterility rather than achieving it, while B65B (packaging) at 6.8% and A61M (body-fluid devices) at 7.0% mark adjacent hardware classes worth watching for cross-filing.
Shares are the percentage of the 979 records in scope. A patent can carry several IPC classes, so the shares add up to more than 100%.
Go deeper on Steam Sterilization and Load Validation with Eureka
This page is one run against one query. Ask Eureka your own question about steam sterilization and load validation and every answer comes back with the patent numbers behind it.
Try EurekaRepresentative filing and most-cited prior art
US20160022853A1 — Post-steam sterilization moisture-indicating articles
Post-steam sterilization wet pack indicators are described. The indicators generally comprise a moisture-impermeable layer having a first surface and a moisture-indicating layer comprising a reversible colorimetric steam-sterilization-compatible moisture-indicating medium. The moisture-indicating layer is disposed on or near the first surface of the moisture-impermeable layer. The area of the moisture-indicating layer is dimensionally smaller than the moisture-impermeable layer such that the edges of the moisture-impermeable layer extend beyond the edges of the moisture-indicating layer. Articles and packages comprising wet pack indicators are also described.Filed by Solventum Intellectual Properties Company, published 2016-01-28.
| # | Publication no. | Patent title | Citations |
|---|---|---|---|
| 1 | US6051747A | Wound dressing and manufacturing method therefor | 259 |
| 2 | US5891076A | Hypertrophic scar dressing | 211 |
| 3 | US6207875B1 | Wound dressing and manufacturing method therefor | 206 |
| 4 | US20090301382A1 | Monitoring System Based on Etching of Metals | 200 |
| 5 | US20090101550A1 | Dialysis system having non-invasive fluid velocity sensing | 164 |
| 6 | US4670227A | Apparatus and method for handling of infectious waste material | 149 |
| 7 | US20090101576A1 | Priming and air removal systems and methods for dialysis | 115 |
| 8 | US8858787B2 | Dialysis system having non-invasive fluid velocity sensing | 114 |
| 9 | US20150374868A1 | Sterilization container capable of providing an indication regarding whether or not surgical instruments ster… | 110 |
| 10 | US20140154808A1 | Monitoring system based on etching of metals | 110 |
Citation counts reflect an older, dominant sub-thread of wound-dressing and monitoring patents inside this corpus; treat them as a signal of past influence rather than current filing direction.
Each row carries its publication number; clicking a row searches Eureka by that number.
Put your own technology through the same analysis
Eureka on the web
When you want the answer in the next five minutes.
The agent works the prompt against patents and technical literature, citing every source.
Run your analysis now →MCP server & REST API
When it has to run inside your own pipeline.
Patent search, landscape analysis and assignee resolution as MCP tools. Drop them into any agent framework, or call REST directly.
Browse MCP servers →What the numbers mean for filing strategy
Three patterns stand out once the ranking, trend and class data are read together.
Half the field sits outside the ranked leaders
The top 5 assignees hold 34.1% of all 979 records and the top 10 hold 51.1%. That leaves close to half the corpus to entities outside the ranked leaders — a sign that validation methodology and indicator design are still being contested by smaller filers rather than settled by a handful of incumbents.
A cool-down from the 2018 peak, not a collapse
Filings peaked at 52 records in 2018 and dropped -76% from 49 in 2021 to 12 in 2024, the last complete year. Because publication lags filing by around 18 months, 2025-2026 figures are still filling in and should not yet be read as confirming further decline.
Proving sterility occupies as much claim space as achieving it
A61L covers 65.5% of records, but G01N (material analysis and testing) at 22.5% and C12Q at 12.9% show that measurement and verification methods draw nearly as much filing attention as the sterilization process itself.
Eureka can read the same corpus for gaps instead of for coverage: under-claimed branches adjacent to steam sterilization and load validation, with the prior art for and against each one.
Who is filing, and where the gate sits
The ranked leaders span sterilizer OEMs, indicator and consumables makers, and a scatter of surgical device firms — but recent-year momentum has gone flat across the names with the largest historical volumes.
A single leader, then a steep drop to the field
The leading assignee holds 108 records against 42 at fifth place and 29 at tenth — a steep early drop-off that flattens into a long tail across the remaining ranked companies.
Historical leaders show no filings in the most recent year
Several of the assignees with the deepest historical portfolios in this dataset show zero filings in the latest year, including year-over-year declines as steep as -100%. Given the 18-month publication lag, this likely reflects incomplete recent-year data as much as a genuine pull-back.
Co-filing is rare and concentrated in one relationship
Only 10 co-assignee pairs appear in the dataset, and one pairing between a major sterilizer group and its healthcare affiliate accounts for the bulk of joint filings. Most other filers, including the largest ones, patent independently.
| Assignee | Recent year | YoY |
|---|---|---|
| 3M Innovative Properties Company | 0 | — |
| Steris Corporation | 0 | -100% |
| American BioGenetic Sciences Inc. | 0 | — |
| Turbett Surgical Inc. | 0 | — |
| MHM IP Ltd. | 0 | — |
| 3M Company | 0 | — |
| Baxter International Inc. | 0 | — |
| SciCan Ltd. | 0 | — |
Where to take this analysis
The dataset points to specific next steps depending on whether the goal is freedom-to-operate, portfolio benchmarking, or identifying open claim space.
Check freedom-to-operate around wet-pack indicators
The representative record and several highly cited prior filings sit in moisture-indicating and wet-pack detection methods. Anyone designing a new indicator should map claims against this cluster before committing to a design.
Explore this cluster in Eureka →Watch for a rebound once 2025-2026 data completes
The apparent -76% decline through 2024 is real for that window, but publication lag means the last two years are not yet a reliable trend signal. Re-check filing volumes once those years mature.
Track filing trends in Eureka →Probe the under-claimed validation-software branches
Automated lethality calculation and cycle qualification data logging show thinner density than the core sterilization class, suggesting room for a differentiated first claim.
Run a white space search in Eureka →Common questions on this landscape
One assignee leads the ranked field with 108 records, well ahead of the fifth-place holder at 42 and tenth place at 29. The top 5 assignees together hold 34.1% of all 979 records in scope, and the top 10 hold 51.1%, meaning roughly half the field is spread across a long tail of smaller filers. This pattern suggests the leading names set the baseline validation methods, but plenty of room remains for differentiated filings outside that group.
Filing peaked at 52 records in 2018 and has since declined, falling -76% from 49 records in 2021 to 12 in 2024, the most recent year that can be treated as complete. Because patent publication typically lags filing by around 18 months, the lower counts recorded for 2025 and 2026 are still incomplete and should not be read as continued decline. A fair read is that the field has cooled from its 2018 peak but the current trajectory is not yet fully visible in the data.
The core class is A61L, sterilising and disinfecting, which appears on 65.5% of the 979 records in this dataset. Testing and measurement methods are also heavily represented: G01N (material analysis and testing) covers 22.5% of records and C12Q (enzyme and DNA-based testing) covers 12.9%. Packaging-related class B65B appears on 6.8% of records, reflecting how much validation technology is built around indicators embedded in sterilization packaging rather than the sterilizer itself.
US20160022853A1, assigned to Solventum Intellectual Properties Company and published in January 2016, claims post-steam-sterilization wet pack indicators built from a moisture-impermeable layer paired with a smaller, reversible colorimetric moisture-indicating layer. The indicating layer's edges sit inside the edges of the impermeable layer, a specific geometric arrangement described in the abstract. Anyone designing a new wet-pack or moisture indicator for steam sterilization should check this layered, dimensionally-offset construction before finalising a competing design.
Based on the technology composition data, claim density is heaviest in A61L (65.5% of records) and in general material testing under G01N (22.5%), while more specific sub-areas such as automated lethality calculation, real-time air-removal sensing, and packaging-integrated penetration indicators show comparatively thinner coverage. These are not zero-filing areas, but they sit below the density of the core sterilization and general testing classes, which is where a well-drafted first claim has the best chance of standing apart from existing prior art.
Research Steam Sterilization and Load Validation in depth with Eureka
Go past this page: query the whole steam sterilization and load validation corpus yourself, in your own scope.
Every answer comes back with patent numbers you can open.
Disclaimer. This page is generated from Patsnap Eureka data drawn from a limited snapshot of global patent and scientific-literature records, and is provided for general information and reference only.
Patent data carries inherent limitations: recent filings (typically the most recent 18–24 months) are under-counted due to standard publication lag; counts may be reported at either a patent-family or a patent-record basis and are not always directly comparable; classification, applicant-name, and citation data may contain errors, duplicates, or omissions; and the underlying search query defines and constrains the scope shown. As a result, the analysis may be incomplete or inaccurate and may not reflect the full technology landscape.
Nothing on this page constitutes an exhaustive prior-art, novelty, freedom-to-operate, or validity search, nor does it constitute legal, financial, investment, or professional advice, and it should not be relied upon as such. Any patent, commercial, or strategic decision should be verified independently and reviewed with qualified patent, legal, and domain professionals. Patsnap makes no warranties, express or implied, as to the accuracy, completeness, or fitness for any particular purpose of the information presented.
Machine translation. Assignee and organisation names originally recorded in Chinese, Japanese or Korean have been rendered into English by an AI translation step so that the tables stay readable. These renderings are best-effort and may not match a company’s registered English name; the original name is what the underlying patent record carries, and it is what any Eureka query launched from this page uses.